Evelo Biosciences, Inc.

GEODE CAPITAL MANAGEMENT, LLC EVLO

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

608,675

Value ($000)

110

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	110	0.0%	608,675	3/31/2023
2022 Q4	2/13/2023	977	0.0%	607,443	12/31/2022
2022 Q3	11/14/2022	1,225	0.0%	586,483	9/30/2022
2022 Q2	8/12/2022	731	0.0%	346,726	6/30/2022
2022 Q1	5/13/2022	1,850	0.0%	545,923	3/31/2022
2021 Q4	2/11/2022	3,178	0.0%	523,575	12/31/2021
2021 Q3	11/12/2021	3,665	0.0%	520,717	9/30/2021
2021 Q2	8/13/2021	6,487	0.0%	472,138	6/30/2021
2021 Q1	5/12/2021	4,127	0.0%	385,734	3/31/2021
2020 Q4	2/12/2021	3,951	0.0%	326,820	12/31/2020
2020 Q3	11/13/2020	1,092	0.0%	207,259	9/30/2020
2020 Q2	8/13/2020	779	0.0%	159,078	6/30/2020
2020 Q1	5/14/2020	531	0.0%	141,430	3/31/2020
2019 Q4	2/13/2020	514	0.0%	126,718	12/31/2019